{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T19:24:50Z","timestamp":1791833090819,"version":"4.3.4"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.semcancer.2017.01.006","type":"journal-article","created":{"date-parts":[[2017,1,22]],"date-time":"2017-01-22T12:16:58Z","timestamp":1485087418000},"page":"139-146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Triple-edged therapy targeting intracellular alkalosis and extracellular acidosis in cancer"],"prefix":"10.1016","volume":"43","author":[{"given":"Tomas","family":"Koltai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.semcancer.2017.01.006_bib0005","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nrc3110","article-title":"Dysregulated pH: a perfect storm for cancer progression","volume":"11","author":"Webb","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcancer.2017.01.006_bib0010","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/1479-5876-11-282","article-title":"Cariporide and other new and powerful NHE1 inhibitors as potentially selective anticancer drugs- an integral molecular\/biochemical\/metabolic\/clinical approach after one hundred years of cancer research","volume":"11","author":"Harguindey","year":"2013","journal-title":"J. Transl. Med."},{"issue":"5","key":"10.1016\/j.semcancer.2017.01.006_bib0015","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.semcancer.2017.01.006_bib0020","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1476-5586(03)80005-2","article-title":"Contributions of cell metabolism and H+ diffusion to the acidic pH of tumors","volume":"5","author":"Schornak","year":"2003","journal-title":"Neoplasia"},{"key":"10.1016\/j.semcancer.2017.01.006_bib0025","article-title":"The Warburg effect and the hallmarks of cancer","volume":"31","author":"Schwartz","year":"2016","journal-title":"Anticancer Agents Med. Chem."},{"issue":"2","key":"10.1016\/j.semcancer.2017.01.006_bib0030","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.molcel.2012.10.025","article-title":"Histone acetylation regulates intracellular pH","volume":"49","author":"McBrian","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.semcancer.2017.01.006_bib0035","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/334438a0","article-title":"Increased pH and tumorigenicity of fibroblasts expressing a yeast proton pump","volume":"334","author":"Perona","year":"1988","journal-title":"Nature"},{"issue":"June","key":"10.1016\/j.semcancer.2017.01.006_bib0040","first-page":"10063","article-title":"The a3 isoform of subunit a of the vacuolar ATPase localizes to the plasma membrane of invasive breast tumor cells and is overexpressed in human breast cancer","volume":"15","author":"Cotter","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2017.01.006_bib0045","unstructured":"https:\/\/clinicaltrials.gov."},{"key":"10.1016\/j.semcancer.2017.01.006_bib0050","doi-asserted-by":"crossref","DOI":"10.4143\/crt.2016.034","article-title":"Proton pump inhibition enhances the cytotoxicity of paclitaxel in cervical cancer","author":"Song","year":"2016","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.semcancer.2017.01.006_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.dld.2016.08.126","article-title":"High doses of proton pumps inhibitors in refractory gastrointestinal cancer: a case series and the state of art","author":"Falcone","year":"2016","journal-title":"Dig. Liver Dis."},{"issue":"39","key":"10.1016\/j.semcancer.2017.01.006_bib0060","doi-asserted-by":"crossref","first-page":"63408","DOI":"10.18632\/oncotarget.11503","article-title":"Altered pH gradient at the plasma membrane of osteosarcoma cells is a key mechanism of drug resistance","volume":"7","author":"Avnet","year":"2016","journal-title":"Oncotarget"},{"issue":"24","key":"10.1016\/j.semcancer.2017.01.006_bib0065","first-page":"12883","article-title":"Sodium\/proton exchange in mouse neuroblastoma cells","volume":"256","author":"Moolenaar","year":"1981","journal-title":"J. Biochem. Chem."},{"key":"10.1016\/j.semcancer.2017.01.006_bib0070","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/304645a0","volume":"304","author":"Moolenaar","year":"1983","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.semcancer.2017.01.006_bib0075","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.1016\/S0021-9258(17)43047-X","article-title":"Blockade of the Na+\/H+ antiport abolishes growth factor induced DNA synthesis in fibroblasts","volume":"259","author":"L\u2019Allemain","year":"1984","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2017.01.006_bib0080","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1073\/pnas.79.13.3935","article-title":"Growth Factor activation of an amiloride-sensitive Na+\/H+ exchange system in quiescent fibroblasts: coupling to ribosomal protein S6 phosphorylation","volume":"79","author":"Pouyssegur","year":"1982","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.semcancer.2017.01.006_bib0085","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1152\/ajpgi.1990.259.5.G842","article-title":"Amiloride and analogues inhibit Na(+)-H+ Exchange and cell proliferation in AR42J pancreatic cell line","volume":"259","author":"Delvaux","year":"1990","journal-title":"Am. J. Physiol. Gastrointest. Liver"},{"issue":"2","key":"10.1016\/j.semcancer.2017.01.006_bib0090","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/sj.bjc.6600424","article-title":"Cytostatic potential of novel agents that inhibit the regulation of intracellular pH","volume":"87","author":"Wong","year":"2002","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.semcancer.2017.01.006_bib0095","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0014-5793(87)80039-X","article-title":"Amiloride selectively inhibits the urokinase-type plasminogen activator","volume":"214","author":"Vassalli","year":"1987","journal-title":"FEBS Lett."},{"issue":"4","key":"10.1016\/j.semcancer.2017.01.006_bib0100","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1016\/S0021-9258(18)89586-2","article-title":"Amiloride directly inhibits growth factor receptor tyrosine kinase activity","volume":"260","author":"Davis","year":"1985","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2017.01.006_bib0105","series-title":"Amiloride and Its Analogs: Unique Cation Transport Inhibitors","first-page":"317","article-title":"Use of Na+\/H+ antiporter inhibitors as a novel approach to cancer treatment","author":"Harguindey","year":"1992"},{"issue":"1","key":"10.1016\/j.semcancer.2017.01.006_bib0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevOncog.v6.i1.20","article-title":"Hydrogen ion-dependent oncogenesis and parallel new avenues to cancer prevention and treatment using a H(+)-mediated unifying approach: pH-related and pH-unrelated mechanisms","volume":"6","author":"Harguindey","year":"1995","journal-title":"Crit. Rev. Oncog."},{"issue":"19","key":"10.1016\/j.semcancer.2017.01.006_bib0115","doi-asserted-by":"crossref","first-page":"16846","DOI":"10.1074\/jbc.M110.187559","article-title":"Angiogenic functions of voltage-gated Na+ channels in human endothelial cells: modulation of vascular endothelial growth factor (VEGF) signaling","volume":"286","author":"Andrikopoulos","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.semcancer.2017.01.006_bib0120","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3892\/ijo.2015.3239","article-title":"Blockade of voltage-gated sodium channels inhibits invasion of endocrine-resistant breast cancer cells","volume":"48","author":"Mohammed","year":"2016","journal-title":"Int. J. Oncol."},{"issue":"32","key":"10.1016\/j.semcancer.2017.01.006_bib0125","doi-asserted-by":"crossref","first-page":"32914","DOI":"10.18632\/oncotarget.5441","article-title":"Nav 1.5 regulates breast tumor growth and metastatic dissemination in vivo","volume":"6","author":"Nelson","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2017.01.006_bib0130","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12943-014-0277-x","article-title":"The sodium channel-blocking antiepileptic drug phenytoin inhibits breast tumour growth and metastasis","volume":"14","author":"Nelson","year":"2015","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.semcancer.2017.01.006_bib0135","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10549-012-2102-9","article-title":"Therapeutic potential for phenytoin: targeting Na(v) 1.5 sodium channels to reduce migration and invasion in metastatic breast cancer","volume":"134","author":"Yang","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"issue":"July (1)","key":"10.1016\/j.semcancer.2017.01.006_bib0140","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00210-010-0519-4","article-title":"5,5-Diphenyl-2-thiohydantoin-N10 (DPTH-N10) suppresses proliferation of cultured colon cancer cell line COLO-205 by inhibiting DNA synthesis and activating apoptosis","volume":"382","author":"Lee","year":"2010","journal-title":"Naunyn. Schmiedebergs Arch. Pharmacol."},{"issue":"3","key":"10.1016\/j.semcancer.2017.01.006_bib0145","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1023\/B:DRUG.0000026253.02502.ce","article-title":"Phase I trial of vinorelbine and diphenylhydantoin in patients with refractory carcinoma","volume":"22","author":"Hutson","year":"2004","journal-title":"Investig. New Drugs"},{"issue":"August","key":"10.1016\/j.semcancer.2017.01.006_bib0150","article-title":"Tumor-reducing effect of the clinically used drug clofazimine in a SCID mouse model of pancreatic ductal adenocarcinoma","volume":"15","author":"Zaccagnino","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.semcancer.2017.01.006_bib0155","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1124\/dmd.106.012369","article-title":"Flavonoids modulate monocarboxylate transporter 1-mediated transport of gammahydroxybutyrate in vitro and in vivo","volume":"35","author":"Wang","year":"2007","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"10.1016\/j.semcancer.2017.01.006_bib0160","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijpharm.2006.02.043","article-title":"Inhibitory effects of statins on human monocarboxylate transporter 4","volume":"317","author":"Kobayashi","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.semcancer.2017.01.006_bib0165","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1517\/13543776.12.2.217","article-title":"Applications of carbonic anhydrase inhibitors and activators in therapy","volume":"12","author":"Supuran","year":"2002","journal-title":"Exp. Opin. Ther. Pat."},{"issue":"8","key":"10.1016\/j.semcancer.2017.01.006_bib0170","first-page":"745","article-title":"Acetazolamide suppresses tumor metastasis and related protein expression in mice bearing Lewis lung carcinoma","volume":"23","author":"Xiang","year":"2002","journal-title":"Acta Pharmacol. Sin."},{"issue":"5","key":"10.1016\/j.semcancer.2017.01.006_bib0175","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1073\/pnas.040554897","article-title":"Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro","volume":"97","author":"Parkkila","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.semcancer.2017.01.006_bib0180","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1186\/1471-2407-13-378","article-title":"Combination of carbonic anhydrase inhibitor, acetazolamide, and sulforaphane, reduces the viability and growth of bronchial carcinoid cell lines","volume":"13","author":"Mokhtari","year":"2013","journal-title":"BMC Cancer"},{"issue":"110\u2013111","key":"10.1016\/j.semcancer.2017.01.006_bib0185","first-page":"1502","article-title":"Acetazolamide inhibits aquaporin-1 expression and colon cancer xenograft tumor growth","volume":"58","author":"Bin","year":"2011","journal-title":"Hepatogastroenterology"},{"issue":"2","key":"10.1016\/j.semcancer.2017.01.006_bib0190","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/cbin.10197","article-title":"Acetazolamide triggers death induced autophagy in T-47D breast cancer cells","volume":"38","author":"Mohammadpour","year":"2014","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.semcancer.2017.01.006_bib0195","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3390\/i8030229","article-title":"Effects of acetazolamide combined with or without NaCO3 on suppressing neoplasm growth, metastasis and Aquaporin-1 (AQP1) protein expression","volume":"8","author":"Li","year":"2007","journal-title":"Int. J. Mol. Sci."},{"issue":"June (7503)","key":"10.1016\/j.semcancer.2017.01.006_bib0200","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/bmj.38415.708634.F7","article-title":"Metformin and reduced risk of cancer in diabetic patients","volume":"330","author":"Evans","year":"2005","journal-title":"Br. Med. J."},{"issue":"October","key":"10.1016\/j.semcancer.2017.01.006_bib0205","article-title":"Activation of AMP-activated protein kinase by metformin induces protein acetylation in prostate and ovarian cancer cells","volume":"12","author":"Galdieri","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.semcancer.2017.01.006_bib0210","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/0006-2952(81)90403-2","article-title":"Tissue distribution and effects on mitochondrial protein synthesis of tetracyclines after prolonged continuous intravenous administration to rats","volume":"30","author":"Van den Bogert","year":"1981","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.semcancer.2017.01.006_bib0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114457","article-title":"Cytotoxic effects of tetracycline analogs (doxycycline, minocycline and col-3) in acute myeloid leukemia HL-60 cells","author":"Song","year":"2014","journal-title":"PLoS One"},{"issue":"June (23)","key":"10.1016\/j.semcancer.2017.01.006_bib0220","doi-asserted-by":"crossref","first-page":"34084","DOI":"10.18632\/oncotarget.9122","article-title":"Repurposing atovaquone: targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells","volume":"7","author":"Fiorillo","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.semcancer.2017.01.006_bib0225","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0022-3565(25)23666-7","article-title":"In vitro effects of ciprofloxacin and pefloxacin on growth of normal human hematopoietic progenitor cells and on leukemic cell lines","volume":"248","author":"Somekh","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.semcancer.2017.01.006_bib0230","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/jcb.240510208","article-title":"4-Quinolones cause a selective loss of mitochondrial DNA from mouse L1210 leukemia cells","volume":"51","author":"Lawrence","year":"1993","journal-title":"J. Cell. Biochem."},{"issue":"6","key":"10.1016\/j.semcancer.2017.01.006_bib0235","first-page":"939","article-title":"Effects of brequinar and ciprofloxacin on de novo nucleotide biosynthesis in mouse L1210 leukemia","volume":"22","author":"Lyons","year":"1990","journal-title":"Biochem. Int."},{"issue":"5","key":"10.1016\/j.semcancer.2017.01.006_bib0240","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/S0026-895X(25)09546-X","article-title":"Delayed cytotoxicity and cleavage of mitochondrial DNA in ciprofloxacin \u2013treated mammalian cells","volume":"50","author":"Lawrence","year":"1996","journal-title":"Mol. Pharmacol."},{"issue":"6","key":"10.1016\/j.semcancer.2017.01.006_bib0245","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/BF02994093","article-title":"Ability of four potential topoisomerase II inhibitors to enhance the cytotoxicity of diamminedichloroplatinum (II) in Chinese hamster ovary cells in an epipodophyllotoxin-resistant subline","volume":"26","author":"Eder","year":"1990","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"6","key":"10.1016\/j.semcancer.2017.01.006_bib0250","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.3892\/ijo.2012.1653","article-title":"Ciprofloxacin is a potential topoisomerase II inhibitor for the treatment of NSCLC","volume":"41","author":"Kloskowski","year":"2012","journal-title":"Int. J. Oncol."},{"issue":"10","key":"10.1016\/j.semcancer.2017.01.006_bib0255","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1084\/jem.20021952","article-title":"Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion","volume":"197","author":"Boya","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.semcancer.2017.01.006_bib0260","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1562\/0031-8655(2000)072<0458:AOTEPB>2.0.CO;2","article-title":"Alteration of the endocytotic pathway by photosensitization with fluoroquinolones","volume":"72","author":"Ouedraogo","year":"2000","journal-title":"Photochem. Photobiol."},{"issue":"1","key":"10.1016\/j.semcancer.2017.01.006_bib0265","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1073\/pnas.0408592102","article-title":"Induction of lysosomal membrane permeabilization by compounds that activate p-53 independent apoptosis","volume":"102","author":"Erdal","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"October","key":"10.1016\/j.semcancer.2017.01.006_bib0270","article-title":"Critical functions of the lysosome in cancer biology","volume":"12","author":"Davidson","year":"2016","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"25","key":"10.1016\/j.semcancer.2017.01.006_bib0275","doi-asserted-by":"crossref","first-page":"38078","DOI":"10.18632\/oncotarget.9348","article-title":"Derivatives of 6-cinnamamido-quinoline-4-carboxamide impair lysosome function and induce apoptosis","volume":"7","author":"Kio","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.semcancer.2017.01.006_bib0280","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000448802","article-title":"Lysosome inhibitors enhance the chemotherapeutic activity of doxorubicin in HepG2 cells","volume":"62","author":"Li","year":"2016","journal-title":"Chemotherapy"},{"issue":"September (3)","key":"10.1016\/j.semcancer.2017.01.006_bib0285","first-page":"264","article-title":"Manipulating tumor acidification as a cancer treatment strategy","volume":"15","author":"McCarty","year":"2010","journal-title":"Altern. Med. Rev."},{"key":"10.1016\/j.semcancer.2017.01.006_bib0290","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1158\/0008-5472.CAN-08-2394","article-title":"The potential role of systemic buffers in reducing intratumoral extracellular pH and acid-mediated invasion","volume":"69","author":"Silva","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2017.01.006_bib0295","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1158\/0008-5472.CAN-08-2470","article-title":"Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH","volume":"69","author":"Chiche","year":"2009","journal-title":"Cancer Res."},{"issue":"22","key":"10.1016\/j.semcancer.2017.01.006_bib0300","doi-asserted-by":"crossref","first-page":"10627","DOI":"10.1158\/0008-5472.CAN-07-1805","article-title":"Targeting Vacuolar H+-ATPases as a new strategy against cancer","volume":"67","author":"Fais","year":"2007","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.semcancer.2017.01.006_bib0305","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/bjc.1996.254","article-title":"The chronic administration of drugs that inhibit the regulation of intracellular pH: in vitro and anti-tumour effects","volume":"73","author":"Yamagata","year":"1996","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.semcancer.2017.01.006_bib0310","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1111\/bph.12773","article-title":"Utilizing hydrogen sulphide as a novel anti-cancer agent by targeting glycolysis and pH imbalance","volume":"171","author":"Lee","year":"2014","journal-title":"Br. J. Pharmacol."},{"issue":"14","key":"10.1016\/j.semcancer.2017.01.006_bib0315","first-page":"5630","article-title":"Absence of Crabtree effect in human melanoma cells adapted to growth at low pH","volume":"611","author":"Burd","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2017.01.006_bib0320","doi-asserted-by":"crossref","first-page":"10823","DOI":"10.1038\/ncomms10823","article-title":"Melanoma cell lysosome secretory burst neutralizes the CTL-mediated cytotoxicity at the lytic synapse","volume":"7","author":"Khazen","year":"2016","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.semcancer.2017.01.006_bib0325","doi-asserted-by":"crossref","first-page":"e1500603","DOI":"10.1126\/sciadv.1500603","article-title":"Regulated lysosomal exocytosis mediates cancer progression","volume":"1","author":"Machado","year":"2015","journal-title":"Sci. Adv."},{"issue":"44","key":"10.1016\/j.semcancer.2017.01.006_bib0330","doi-asserted-by":"crossref","first-page":"31761","DOI":"10.1074\/jbc.M113.514091","article-title":"P-glycoprotein mediates drug resistance via a novel mechanism involving lysosomal sequestration","volume":"284","author":"Yamagishi","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"29","key":"10.1016\/j.semcancer.2017.01.006_bib0335","doi-asserted-by":"crossref","first-page":"28057","DOI":"10.18632\/oncotarget.4812","article-title":"V-ATPase: a master effector of E2F1-mediated lysosomal trafficking, mTORC1 activation and autophagy","volume":"6","author":"Meo-Evoli","year":"2015","journal-title":"Oncotarget"},{"issue":"19","key":"10.1016\/j.semcancer.2017.01.006_bib0340","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1002\/ijc.28562","article-title":"V-ATPase inhibition by archazolid leads to lysosomal dysfunction resulting in impaired cathepsin B activation in vivo","volume":"134","author":"Kubisch","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.semcancer.2017.01.006_bib0345","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1152\/advan.00045.2004","article-title":"Regulation of intracellular pH","volume":"28","author":"Boron","year":"2004","journal-title":"Adv. Physiol. Educ."},{"key":"10.1016\/j.semcancer.2017.01.006_bib0350","doi-asserted-by":"crossref","first-page":"20130107","DOI":"10.1098\/rstb.2013.0107","article-title":"Targeting ion transport in cancer","volume":"369","author":"Oosterwijk","year":"2014","journal-title":"Philos. Trans. R. Soc."},{"key":"10.1016\/j.semcancer.2017.01.006_bib0355","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1006\/jtbi.1998.0836","article-title":"Mathematical modelling of tumor acidity: regulation of intracellular pH","volume":"196","author":"Webb","year":"1999","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.semcancer.2017.01.006_bib0360","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bbabio.2004.05.007","article-title":"Wages of Fear: transient threefold decrease in intracellular ATP level imposes apoptosis","volume":"1658","author":"Izyumov","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.semcancer.2017.01.006_bib0365","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1128\/AAC.46.3.821-827.2002","article-title":"Neurotoxic mode of action of artemisinin","volume":"46","author":"Schmuck","year":"2002","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X17300068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X17300068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T14:24:46Z","timestamp":1749911086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X17300068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":73,"alternative-id":["S1044579X17300068"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2017.01.006","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Triple-edged therapy targeting intracellular alkalosis and extracellular acidosis in cancer","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2017.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}